i3 Verticals Q3 FY2026 slides: recurring revenue rises amid challenges

i3 Verticals reported Q3 revenue of $53.1M (+2% YoY) that missed expectations, while recurring revenue rose to 82% of total and ARR increased 8% YoY to $174.1M; the stock fell 8.93% premarket. Profitability improved with adjusted diluted EPS of $0.4224 vs a $0.254 consensus (+66.3%) and adjusted EBITDA up 5% YoY to $13.3M (25% margin). However, the company cut FY2026 guidance to $216M–$221M revenue and $57M–$60M adjusted EBITDA, citing ~$4.5M pressure in professional services and >$1M transaction weakness, and tempered FY2027 growth to mid-single digits. Analysts still see $27–$30 price targets (~30% upside), but sentiment remains focused on execution risk.

Analysis

IIIV is still being valued like a quasi-SaaS platform, but the current numbers say the mix shift is incomplete: the market is paying for recurring revenue durability while management is still exposed to lumpy implementation and transaction volumes. That creates a classic multiple-risk setup where even modest top-line misses can compress the forward EV/ARR and EV/EBITDA bridge faster than operating leverage can rebuild it. The near-term losers are small-cap vertical software names with mixed services/transactions exposure; the relative winners are cleaner recurring-revenue peers with higher organic growth and fewer project delays.

The second-order issue is that the EPS beat is partly mechanical: buybacks and non-core gains can mask slower underlying growth, so the stock may not get credit for margin improvement unless revenue re-accelerates. If the Q4 data fix on interchange restores transaction revenue, the stock can bounce sharply because the selloff has already de-rated it toward the bottom of its range. But if guidance resets again or FY27 growth stays mid-single-digit, investors will likely stop underwriting the “ARR transition” story and value it more like a low-growth payments/software hybrid.

Contrarian view: the downside may be somewhat front-loaded because the balance sheet has enough liquidity to absorb a few weak quarters, and cost discipline can keep EBITDA from rolling over immediately. Still, the market is likely underestimating how much of the current EPS quality is non-recurring in nature. Falsifier for the bearish read is two consecutive quarters of organic growth inflection plus a clean transaction revenue recovery; absent that, rallies should fade into strength rather than be chased.

Key Decisions for Investors

• Short IIIV on any post-earnings relief rally back toward the low-$20s; thesis is multiple compression if FY27 growth remains mid-single digits. Use a 1-3 month horizon and cover if the stock reclaims pre-earnings levels and holds for several sessions.
• For options-aware accounts, buy 2-4 month put spreads on IIIV rather than outright puts; the setup is event-driven but not broken enough to justify paying full downside convexity after the initial gap.
• Pair: long cleaner vertical software/recurring-revenue names with higher organic growth against short IIIV. The relative-value expression is that the market will pay up for revenue quality once execution risk becomes visible again.
• Watch Q4 for the interchange data fix and utilities project conversion rate. If transaction revenue and professional services both re-accelerate, the bearish thesis is invalidated and shorts should be cut quickly.